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TO THE EDITOR
Epidermal growth factor receptor
(EGFR) activity is essential for skin and
hair follicle homeostasis and its dereg-
ulation results in a series of disorders,
including psoriasis and cancer (Sibilia
et al., 2007; Pastore et al., 2008;
Schneider et al., 2008b). Further, in-
flammatory rash, dry skin, and hair and
periungual alterations are common
side-effects in cancer patients treated
with EGFR tyrosine kinase inhibitors
and anti-EGFR monoclonal antibodies
(Lacouture, 2006). The EGFR can be
activated by a family of seven peptide
growth factors (Schneider and Wolf,
2009). Upon ligand binding, EGFR
homodimers or heterodimers (with the
related ERBB receptors) are formed,
resulting in the activation of multiple
signaling cascades (Yarden and Shilo,
2007). EGFR ligands are not redundant,
but rather exert distinctive and specific
biological functions. For example,
alterations of the expression levels of
different EGFR ligands in the skin
resulted in very diverse cutaneous
phenotypes (reviewed in (Schneider
et al., 2008b).
Epigen is the newest and least
characterized EGFR ligand (Strachan
et al., 2001; Kochupurakkal et al.,
2005). In spite of its much lower affinity
for the EGFR, epigen is more mitogenic
than EGF due to less effective receptor-
mediated ligand depletion and a rather
inefficient receptor ubiquitylation and
down-regulation (Kochupurakkal et al.,
2005). To study its biological activities,
we generated transgenic mice over-
expressing human epigen under the
control of the CMV enhancer/chicken
beta-actin promoter. This promoter can
drive expression of transgenes in the
pilosebaceous unit and the interfollicu-
lar epidermis, among many other tis-
sues (Schneider et al., 2008a). Six
founder mice (EPGN-tg) with different
integration sites of the transgene were
obtained. They were visibly smaller
than their non-transgenic littermates
and development of the first coat was
obviously delayed (Figure 1a). Once
hair became visible, it grew in a patchy
pattern and appeared greasy (Figure
1b,c).
Although EPGN-tg mice were not
sterile, they generated small litters and
consistently failed to produce trans-
genic descendants (except for one
founder, which produced a litter with
a single transgenic pup). EPGN-tg
founder mice were therefore sacrificed,
and expression of the transgene in the
skin was confirmed by Northern blot-
ting (Figure 1d). Histological examina-
tion of hematoxylin-eosin-stained back
skin and tail skin sections (Figure 1e)
and immunofluorescence against the
lipid-associated protein adipophilin
(Figure 1f) demonstrated strongly en-
larged sebaceous glands. Quantitative
analysis revealed a significant increase
in the area occupied by sebaceous
glands in the skin of EPGN-tg mice
compared to non-transgenic littermates
(Figure 1g), further suggesting that the
greasy fur of the mice was a conse-
quence of increased sebum production.
However, since measurements of epi-
dermal sebum levels or quantification
of sebum production could not be
performed, it cannot be excluded that
the greasy aspect of the coat is a
consequence of structural changes in
the hair shaft. The absence of overt
phenotypical alterations in other organs
from EPGN-tg mice (data not shown)
indicates that the skin is particularly
sensitive to increased levels of epigen.
Immunofluorescence localized a few
epigen-positive cells in the interfollicu-
lar epidermis of tail skin and in the
outer root sheath of the hair follicle of
non-transgenic animals (Supplementary
Figure 1a), confirming a previous report
(Strachan et al., 2001; Kochupurakkal
et al., 2005). Interestingly, we observed
that epigen is expressed both in un-
differentiated and in differentiated se-
bocytes in EPGN-tg mice, but only in
differentiated sebocytes in control lit-
termates (Supplementary Figure 1b).
Overall, the number of epigen-positive
cells in EPGN-tg mice was significantly
higher (Supplementary Figure 1). Since
mouse and human epigen protein
sequences are highly conserved (82%
identity), we assume that this observa-
tion reflects the detection of both
endogenous (mouse) and transgenic
(human) epigen in EPGN-tg mice.
We next investigated the mechanism
underlying the sebaceous gland
enlargement. Cell counting revealed a
2.5-fold increase in the average cell
number/gland in EPGN-tg mice com-
pared to controls (Figure 2a). BrdU
incorporation studies showed that the
number of proliferating cells was strongly
increased in EPGN-tg mice compared to
non-transgenic littermates (Figure 2b).
This finding, together with expression of
transgene-derived epigen in undifferen-
tiated sebocytes in EPGN-tg mice, sug-
gests that the enlargement of sebaceous
glands is attributable to expansion of the
basal, undifferentiated cells in the gland
in response to epigen. It will be interest-
ing to determine if Blimp1-expressing
unipotent sebocyte progenitors (Horsley
et al., 2006) are affected by the increased
epigen expression.
Epidermal thickness was visibly in-
creased in transgenic mice, in particu-
lar in the tail skin (Figure 1e). This could
be due to different levels of transgene
expression in the back versus tail skin
or to different responsiveness of tail and
back skin keratinocytes to the increased
epigen levels. Terminal differentiation
of interfollicular keratinocytes was not
obviously affected as revealed by the
appropriate expression of the differen-
tiation markers keratin (K) 10, K14, and
loricin (Figure 2c). In addition, inter-
follicular expression of K6, a marker of
Abbreviations: BrdU, bromodeoxyuridine; CMV, cytomegalovirus; EGFR, epidermal growth factor receptor;
EPGN, epigen; Gapdh, glyceraldehyde-3-phosphate dehydrogenase; TGF-a, transforming growth factor-alpha
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abnormal differentiation and hyperpro-
liferation, was not observed (Figure 2c).
The prominent sebaceous gland
phenotype observed in EPGN-tg mice
is unexpected and differs considerably
from the changes elicited by other
EGFR ligands in transgenic mouse
models. Its presence in six founder
mice demonstrates that the effect is
specific for epigen and does not result
from insertional mutagenesis. Overex-
pression of amphiregulin resulted in a
psoriasis-like phenotype (Cook et al.,
1997, 2004), increased levels of EGF
caused hyperproliferation of basal cells
and hair follicle developmental arrest
(Mak and Chan, 2003), betacellulin
transgenic animals showed a relatively
mild skin phenotype, including delayed
hair cycle induction and increased
angiogenesis at wound sites (Schneider
et al., 2008a), and overexpression of
TGF-a resulted in a hyperproliferative,
tumor-prone skin (Vassar and Fuchs,
1991; Dominey et al., 1993). Thus, our
findings support the concept that EGFR
ligands are not redundant, but exert
distinct and specific functions. The
enlarged sebaceous glands of EPGN-tg
mice, together with the observation of
endogenous epigen expression in this
appendage, suggest a role for epigen in
sebocyte physiology and a potential
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Figure 1. Phenotypic alterations in transgenic mice overexpressing Epigen. (a-c) Macroscopic appearance of control and EPGN-tg mice (identified by
asterisks) at the ages of 2 (a), 6 (b), and 12 (c) weeks of age. (d) Northern blot showing expression of the transgene in the skin of transgenic mice.
Hybridization with a Gapdh probe served as a loading control. (e) H&E staining of the back skin (left) and tail skin (right) showing the normal size of the
sebaceous glands in an adult control mouse (top panel, arrows) and the remarkable hyperplasia of the sebaceous glands in EPGN-tg mice (low panel).
(f) Immunofluorescence staining against adipophilin showing large amounts of lipids in the skin of EPGN-tg mice. (g) Quantitative evaluation of sebaceous
gland area in EPGN-tg mice (n¼5) as compared to aged-matched, non transgenic mice (n¼ 4). Bars represent 100mm (e,f); ** in (g) indicate statistical
significance, Po0.01.
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application of this growth factor for the
modulation of sebum production. Gen-
eration of transgenic mouse lines with
skin-specific overexpression of epigen
will be required to further study the
influence of epigen on the appendages
and the interfollicular epidermis.
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Polymorphic Light Eruption Occurs in 18% of Europeans
and Does Not Show Higher Prevalence with Increasing
Latitude: Multicenter Survey of 6,895 Individuals Residing
from the Mediterranean to Scandinavia
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TO THE EDITOR
Polymorphic light eruption (PLE) is
acknowledged to be the most common
idiopathic photodermatosis, but epide-
miological data are sparse. From sur-
veys in 550 people in Perth and Ballarat
(Australia) and London (UK), PLE pre-
valence was estimated at 5.2, 3.6, and
14.8%, respectively (Pao et al., 1994),
whereas a postal questionnaire of 397
Swedish subjects showed symptoms of
PLE in 21% (Ros and Wennersten,
1986), and from 271 Boston (USA)
residents the prevalence of PLE was
estimated at 11% (Morison and Stern,
1982). These investigations led to the
assumption that PLE prevalence is
lower in countries nearer the equator,
whereas latitudes with higher seasonal
UV radiation modulation may predis-
pose to the condition. However, reli-
able data concerning this hypothesis
are lacking. In our large-scale cross-
sectional study, we assessed PLE pre-
valence in the adult population of six
European countries located from the
Mediterranean to Scandinavia.
Participating centers were university
dermatology departments in Athens
(Greece, NL 381), Besanc¸on (France,
471), Heidelberg (Germany, 49.51),
Leiden (The Netherlands, 521), Man-
chester (UK, 53.51), and Turku (Finland,
60.51). All subjects were indoor work-
ers, predominantly hospital staff,
whereas factory workers were included
in Heidelberg. Interviewees completed
a questionnaire under the supervision
of an investigator at each center. A
short (one-page) questionnaire was de-
veloped to encourage high response
(Figure S1). The first part of this ques-
tionnaire asked questions regarding
skin type, age, and sex, together with
the central question, ‘‘Do you get an
itching rash/abnormal skin after short
sun exposures, which you do not regard
as sunburn?’’ Interviewees answering
‘‘yes’’ continued the questionnaire,
including questions on occurrence
during springtime and sunny holidays,
age at first appearance, timing of
appearance after sun exposure, and
duration. Ethics approval was gained
at participating institutions, informed
consent was obtained, and the study
adhered to the Declaration of Helsinki
Principles. Data were collected
from March 2003 to April 2004. To
estimate a prevalence of 10% with
accuracy±2%, a sample size of 1,000
was required. Statistical analyses were
carried out in Heidelberg using SAS 9.1
Windows (Cary, NC).
The interviewed cohorts are charac-
terized in Table 1a and the subgroups
with PLE features in Table 1b. A
response rate of 490% was achieved
at each center, with an overall total of
6,895 respondents (62.8% women,
37.2% men). Of 6,836 subjects with
complete questionnaires, 1,235 gave a
history consistent with PLE, giving a
suspected lifetime prevalence of PLE of
18% in the study population (18.2%
after age and sex standardization). A
similar age and sex-standardized pre-
valence (range 17–19.5%), was found
among centers, apart from a low pre-
valence of 13.6% in Turku.
PLE rashes were reported to occur
during springtime by equal proportions
of the total interviewed population per
country (between 7 and 10%), without
indication of a latitudinal gradient
(Table 1b). Frequency of PLE during
sunny holidays in the total population
was strikingly low among Finnish parti-
cipants (9%), compared with other
countries (14–20%), explaining the
overall low prevalence of PLE in Fin-
land. Among people with PLE, theAbbreviations: PLE, polymorphic light eruption
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